世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

外科用シーラント・接着剤市場:製品別[天然/生物学的外科用シーラント・接着剤(ポリペプチド/タンパク系シーラント・接着剤、多糖類系シーラント・接着剤)、合成・半合成シーラント・接着剤(シアノアクリレート、ポリエチレングリコール系ハイドロゲル、ウレタン系接着剤、その他の合成シーラント・接着剤)]、適応別(組織シーリング・止血、組織エンジニアリング)、用途別(中枢神経系手術、一般手術、心血管手術、整形外科手術、美容整形手術、眼科手術、泌尿器科手術、肺手術、その他) - 世界の機会分析と産業予測 2017-2023年

Surgical Sealants and Adhesives Market by Product [Natural/Biological Surgical Sealants & Adhesives (Polypeptide/Protein-based Sealants & Adhesives and Polysaccharide-based Sealants & Adhesives) and Synthetic & Semisynthetic Sealants and Adhesives (Cyanoacrylates, Polyethylene Glycol-based Hydrogel, Urethane-based Adhesives, and Other Synthetic Sealants and Adhesives)], Indication (Tissue Sealing & Hemostasis and Tissue Engineering), and Application (Central Nervous System Surgeries, General Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Cosmetic Surgeries, Ophthalmic Surgeries, Urological Surgeries, Pulmonary Surgeries, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 

出版社 出版年月電子版価格 ページ数
Allied Market Research
アライドマーケットリサーチ
2018年3月US$5,370
シングルユーザライセンス
311

サマリー

この調査レポートは外科用シーラント・接着剤市場を分析・予測したAllied Market Researchの市場調査報告書です。

Description

The global surgical sealants and adhesives market was valued at $1,993 million in 2016, and is expected to reach $3,794 million by 2023, registering a CAGR of 9.7% from 2017 to 2023. Surgical sealants and adhesives are preferred over traditional closure methods such as wires, sutures, and staples, as these techniques create immediate and proper sealing. Surgical sealants and adhesives are expected to replace sutures and staples, owing to their improved closure capabilities, less blood loss, higher implementation rate facilitating less painful operation. Moreover, they are applicable in various surgeries such as central nervous system, general surgery, cardiovascular, pulmonary, ophthalmology, orthopedic, urology, and other surgeries.

Urgent need to minimize blood loss in patients and increase in cases of surgical procedures occurring across different countries are the key factors driving the growth of the surgical sealants and adhesives market. Furthermore, surge in adoption of technological advanced products along with certification by regulatory authorities is expected to boost the market growth. However, improper reimbursements in case of surgical adhesive and high costs along with huge data requirements for clinical study designing & launching new products are the factors that hamper the growth of the market. On the contrary, upsurge in demand for surgical sealants & adhesives across the emerging nations is anticipated to offer lucrative growth opportunities for the market.

The global surgical sealants and adhesives market is segmented based on product, indication, application, and region. On the basis of product, the market is bifurcated into natural/biological sealants & adhesives and synthetic & semisynthetic sealants and adhesives. Natural/biological sealants and adhesives are further segmented into by type and by origin. By type, natural/biological sealants and adhesives are classed into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and adhesives are subsegmented into fibrin based, collagen based, based, and albumin based. Polysaccharide-based sealants and adhesives are further classified into chitosan based and other polysaccharide based. By origin, natural/biological sealants and adhesives are divided into animal based, human based, and plant based. Synthetic & semisynthetic sealants and adhesives are further segmented into cyanoacrylates, polyethylene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based on indication is fragmented into tissue sealing & hemostasis and tissue engineering. The applications covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS

This report offers a detailed quantitative analysis of the current trends and future estimations from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Product

Natural/Biological Sealants and Adhesives

By Type

Polypeptide/Protein-based Sealants and Adhesives
Fibrin Based
Collagen Based
Gelatin Based
Albumin Based
Polysaccharide-based Sealants and Adhesives
Chitosan Based
Other Polysaccharide Based

By Origin

Human Blood Based
Animal Based
Plant Based

Synthetic and Semisynthetic Sealants and Adhesives

Cyanoacrylates
Polyethylene Glycol-based Hydrogel
Urethane-based Adhesives
Other Synthetic Sealants and Adhesives

By Indication

Tissue Sealing and Hemostasis
Tissue Engineering

By Application

Central Nervous System (CNS) Surgeries
General Surgeries
Cardiovascular Surgeries
Orthopedic Surgeries
Cosmetic Surgeries
Ophthalmic Surgeries
Urological Surgeries
Pulmonary Surgeries
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
Republic of South Africa
Rest of LAMEA

KEY PLAYERS PROFILED

Baxter International Inc.
B. Braun Melsungen AG
Cohera Medical, Inc.
CryoLife Inc.
C.R. Bard Inc.
CSL Limited (CSL Behring)
Johnson & Johnson (Ethicon, Inc.)
Ocular Therapeutix Inc.
Sanofi
Sealantis Ltd.



目次

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top winning strategies, by year, 2015-2018*
3.2.4. Top winning strategies, by development, 2015-2018* (%)
3.2.5. Top winning strategies, by company, 2015-2018*

3.3. Porters five forces analysis
3.4. Top player positioning, 2016
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Increase in ageing population and rise in awareness towards surgical sealants and adhesives
3.5.1.2. Surge in prevalence of chronic diseases and rise in surgical procedures conducted globally
3.5.1.3. Surge in adoption of technologically advanced products

3.5.2. Restraints

3.5.2.1. High cost and extensive clinical data required for the launch of new surgical sealants and adhesives
3.5.2.2. Popularity of minimally invasive surgeries

3.5.3. Opportunity

3.5.3.1. Introduction of novel surgical sealants and adhesives and rise in healthcare spending

CHAPTER 4: SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT

4.1. Overview
4.2. Market size and forecast
4.3. Natural/biological surgical sealants and adhesives

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Natural/biological sealants and adhesives, by type

4.3.3.1. Market size and forecast
4.3.3.2. Polypeptide/protein-based sealants and adhesives

4.3.3.2.1. Market size and forecast
4.3.3.2.2. Fibrin based

4.3.3.2.2.1. Market size and forecast

4.3.3.2.3. Collagen based

4.3.3.2.3.1. Market size and forecast

4.3.3.2.4. Gelatin based

4.3.3.2.4.1. Market size and forecast

4.3.3.2.5. Albumin based

4.3.3.2.5.1. Market size and forecast

4.3.3.3. Polysaccharide-based sealants and adhesives

4.3.3.3.1. Market size and forecast
4.3.3.3.2. Chitosan based

4.3.3.3.2.1. Market size and forecast

4.3.3.3.3. Other polysaccharide based

4.3.3.3.3.1. Market size and forecast

4.3.4. Natural/biological sealants and adhesives, by origin

4.3.4.1. Market size and forecast
4.3.4.2. Human blood based

4.3.4.2.1. Market size and forecast

4.3.4.3. Animal based

4.3.4.3.1. Market size and forecast

4.3.4.4. Plant based

4.3.4.4.1. Market size and forecast

4.4. Synthetic & semisynthetic sealants and adhesives

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market size and forecast
4.4.4. Cyanoacrylates

4.4.4.1. Market size and forecast

4.4.5. Polyethylene glycol-based hydrogel

4.4.5.1. Market size and forecast

4.4.6. Urethane-based adhesives

4.4.6.1. Market size and forecast

4.4.7. Other synthetic sealants and adhesives

4.4.7.1. Market size and forecast

CHAPTER 5: SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Central nervous system (CNS) surgeries

5.2.1. Market size and forecast, by region

5.3. General surgeries

5.3.1. Market size and forecast, by region

5.4. Cardiovascular surgeries

5.4.1. Market size and forecast, by region

5.5. Orthopedic surgeries

5.5.1. Market size and forecast, by region

5.6. Cosmetic surgeries

5.6.1. Market size and forecast, by region

5.7. Ophthalmic surgeries

5.7.1. Market size and forecast, by region

5.8. Urological surgeries

5.8.1. Market size and forecast, by region

5.9. Pulmonary surgeries

5.9.1. Market size and forecast, by region

5.10. Others

5.10.1. Market size and forecast, by region

CHAPTER 6: SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Tissue sealing & hemostasis

6.2.1. Market size and forecast, by region

6.3. Tissue engineering

6.3.1. Market size and forecast, by region

CHAPTER 7: SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by product
7.2.3. Market size and forecast, by indication
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country

7.2.5.1. U.S. market size and forecast
7.2.5.2. Canada market size and forecast
7.2.5.3. Mexico market size and forecast

7.3. Europe

7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by product
7.3.3. Market size and forecast, by indication
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by country

7.3.5.1. Germany market size and forecast
7.3.5.2. UK market size and forecast
7.3.5.3. France market size and forecast
7.3.5.4. Italy market size and forecast
7.3.5.5. Spain market size and forecast
7.3.5.6. Rest of Europe market size and forecast

7.4. Asia-Pacific

7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by product
7.4.3. Market size and forecast, by indication
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by country

7.4.5.1. Japan market size and forecast
7.4.5.2. China market size and forecast
7.4.5.3. India market size and forecast
7.4.5.4. Australia market size and forecast
7.4.5.5. South Korea market size and forecast
7.4.5.6. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by product
7.5.3. Market size and forecast, by indication
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by country

7.5.5.1. Brazil market size and forecast
7.5.5.2. South Africa market size and forecast
7.5.5.3. Saudi Arabia market size and forecast
7.5.5.4. Rest of LAMEA market size and forecast

CHAPTER 8: COMPANY PROFILES

8.1. Baxter International Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. B. Braun Melsungen AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. Cohera Medical, Inc.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Key strategic moves and developments

8.4. CryoLife Inc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. C.R. Bard Inc.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance

8.6. CSL Limited (CSL Behring)

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance

8.7. Johnson & Johnson (Ethicon, Inc.)

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. Ocular Therapeutix Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Business performance

8.9. Sanofi

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. Sealantis Ltd.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る